104 countries. 7 continents. 1052 water samples. 258 rivers.

The Global Monitoring of Pharmaceuticals Project emerged out of a pursuit to better understand the extent and drivers of the medicinal contamination of freshwater worldwide. As the first truly global and largest study of its kind, the project assembled  a network of over 120 collaborators worldwide. Concentrations of 61 pharmaceuticals were measured across 104 countries, more than were previously available in the literature. Thirty-si of these countries had never been studied for the occurrence of pharmaceuticals in surface water before. 

​

​

​

​

Africa:

Angola

Cameroon

Burkina Faso

Benin

Congo (Republic of)

Congo (Democratic Republic of)

Ethiopia

Gambia (The)

Ghana

Ivory Coast

Kenya

Lesotho

Liberia

Mali

Morocco

Nigeria

Rwanda

Sierra Leone

South Africa

South Sudan

Tanzania

Tunisia

Uganda

Zimbabwe

​

Antarctica:

King George Island

​

Asia:

Armenia

Bangladesh

Bhutan

Brunei

China

Georgia

Hong Kong

India

Indonesia

Iran

Iraq

Israel

Japan

Kazakhstan

Laos

Malaysia

Pakistan

Palestine

Philippines

South Korea

Sri Lanka

Taiwan

Thailand

Turkey

​

Europe:

Albania

Austria

Belgium

Bulgaria

Croatia

Cyprus

Czech Republic

Denmark

England

Estonia

Finland

France

Germany

Greece

Hungary

Iceland

Ireland

Italy

Latvia

Lithuania

Luxembourg

Netherlands

Northern Ireland

Norway

Poland

Portugal

Romania

Russia

Scotland

Serbia

Slovakia

Slovenia

Spain

Sweden

Switzerland

Ukraine

Wales

​

North America:

Antigua

Canada

Costa Rica

Mexico

Panama

United States

​

Oceania:

Australia

Cook Islands

New Zealand

​

South America:

Argentina

Bolivia

Brazil

Chile

Colombia

Ecuador

Peru

Uruguay

Venezuela

​

​

​